Exercise may decrease heart drug's effectiveness

March 8, 2018, Simon Fraser University

Peter Ruben and his team of researchers have spent years studying why seemingly healthy patients with inherited cardiac arrhythmias can sometimes suddenly die during exercise. (2017, 2016, 2015) His past research has shown that exercising can trigger a perfect storm of events, unmasking an arrhythmia: high heart rate, elevated body temperature, and elevated acid in the blood.

Now the team has dug deeper and discovered that some of these physiological changes accompanying exercise, particularly elevated body temperature and elevated heart rate, might also decrease the ability of Ranolazine to maintain a healthy heart rhythm during exercise.

Ranolazine is a second-line therapeutic agent prescribed for , for which chest pain is the main symptom. It works to improve blood flow to help the heart work more effectively and also has been effective in treating those with some inherited arrhythmias.

Knowing that external triggers can affect drug-channel interaction, Ruben's team was keen to test Ranolazine's efficacy under various physiological states.

They discovered that increased body temperature and reduce the potential effectiveness of Ranolazine to exert its anti-arrhythmic effects in one of the most common forms of inherited arrhythmia.

Ruben advises physicians to caution patients who take Ranolazine for this form of inherited arrhythmia (and perhaps others yet to be tested) that it may work well while the patient is resting, but could lose its effectiveness during exercise. "This is important because exercise can trigger a catastrophic arrhythmia in these patients, and Ranolazine could not be expected to control the arrhythmia in those patients during ." says Ruben.

Explore further: Ventricular tachycardia reduced in patients with defibrillators

Related Stories

Ventricular tachycardia reduced in patients with defibrillators

May 15, 2017
A drug approved to treat chest pain reduces the incidence of a common arrhythmia called ventricular tachycardia in patients with an implantable cardioverter defibrillator (ICD), according to a study presented today at the ...

Body temperature change may trigger sudden cardiac death

July 15, 2015
Scientists, including SFU professor Peter Ruben, have found that sudden death caused by cardiac arrhythmia can be triggered by changes in body temperature. The study is published in the Journal of Physiology.

Ranolazine added to glimepiride cuts HbA1c in T2DM

January 18, 2016
(HealthDay)—For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), according to research published ...

Chest pain med is effective for refractory angina, but adherence problematic

April 4, 2011
Ranolazine (Ranexa, Gilead) is an effective anti-anginal therapy in patients with refractory angina; however, at one year only 59 percent of patients remained on the drug, according to a scientific poster that will be presented ...

Ranolazine bests old school antianginal medications

November 2, 2015
(HealthDay)—Newer antianginal (AA) medications such as ranolazine show substantial outcome improvements in chronic stable angina pectoris (CSA) compared to traditional medications, according to a study published in the ...

Angioplasty procedure reduces need for additional drug even when blockages remain

November 11, 2015
Heart patients who had undergone an angioplasty procedure that opened only some blocked arteries tended to have a resolution of their chest pain, making it unnecessary to add another medication to treat the symptom, according ...

Recommended for you

Height may be risk factor for varicose veins, study finds

September 24, 2018
The taller you are, the more likely you are to develop varicose veins, according to a study led by Stanford University School of Medicine researchers that examined the genes of more than 400,000 people in search of clues ...

Physical activity necessary to maintain heart-healthy lifestyle

September 24, 2018
Exercise and physical activity are of vast global importance to prevent and control the increasing problem of heart disease and stroke, according to a review paper published today in the Journal of the American College of ...

Prosthetic valve mismatches common in transcatheter valve replacement, ups risk of death

September 24, 2018
In the largest multi-institutional study to date, led by researchers from Penn Medicine, the team found that among patients who underwent a transcatheter aortic valve replacement (TAVR), a high number experienced severe and ...

Study reveals a promising alternative to corticosteroids in acute renal failure treatment

September 21, 2018
A protein produced by the human body appears to be a promising new drug candidate to treat conditions that lead to acute renal failure. This is shown by a study conducted at São Paulo State University (UNESP) in São José ...

Can a common heart condition cause sudden death?

September 20, 2018
About one person out of 500 has a heart condition known as hypertrophic cardiomyopathy (HCM). This condition causes thickening of the heart muscle and results in defects in the heart's electrical system. Under conditions ...

New drugs could reduce risk of heart disease when added to statins

September 20, 2018
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are in various stages of development, could also reduce blood ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.